Literature DB >> 15894279

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion.

Jianxun Song1, Takanori So, Mary Cheng, Xiaohong Tang, Michael Croft.   

Abstract

Sustained signaling from the T cell receptor (TCR) and costimulatory molecules is thought necessary for generating high numbers of effector T cells. Here, we show that Survivin is controlled in peripheral T cells by OX40 cosignaling via sustained PI3k and PKB activation. Survivin is induced by OX40 independent of mitotic progression in late G1, and blocking Survivin suppresses S-phase transition and division of T cells and leads to apoptosis. Moreover, Survivin expression alone is sufficient to restore proliferation and to antagonize apoptosis in costimulation-deficient T cells and can rescue T cell expansion in vivo. Survivin allows effector T cells to accumulate in large numbers, but Bcl-2 family proteins are required for T cell survival after the phase of active division. Thus, sustained Survivin expression from costimulatory signaling maintains T cell division over time and regulates the extent of clonal expansion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894279     DOI: 10.1016/j.immuni.2005.03.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  103 in total

1.  The human immunodeficiency virus protease inhibitor ritonavir inhibits lung cancer cells, in part, by inhibition of survivin.

Authors:  Anjaiah Srirangam; Monica Milani; Ranjana Mitra; Zhijun Guo; Mariangellys Rodriguez; Hitesh Kathuria; Seiji Fukuda; Anthony Rizzardi; Stephen Schmechel; David G Skalnik; Louis M Pelus; David A Potter
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

Review 2.  Signaling through OX40 enhances antitumor immunity.

Authors:  Shawn M Jensen; Levi D Maston; Michael J Gough; Carl E Ruby; William L Redmond; Marka Crittenden; Yuhuan Li; Sachin Puri; Christian H Poehlein; Nick Morris; Magdalena Kovacsovics-Bankowski; Tarsem Moudgil; Chris Twitty; Edwin B Walker; Hong-Ming Hu; Walter J Urba; Andrew D Weinberg; Brendan Curti; Bernard A Fox
Journal:  Semin Oncol       Date:  2010-10       Impact factor: 4.929

3.  Differential requirements for survivin in hematopoietic cell development.

Authors:  Sandeep Gurbuxani; Yanfei Xu; Ganesan Keerthivasan; Amittha Wickrema; John D Crispino
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-29       Impact factor: 11.205

Review 4.  Role of the Survivin gene in pathophysiology.

Authors:  Fengzhi Li; Michael G Brattain
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

5.  OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling.

Authors:  Takanori So; Heonsik Choi; Michael Croft
Journal:  J Immunol       Date:  2011-02-02       Impact factor: 5.422

6.  Antigen-independent signalosome of CARMA1, PKCθ, and TNF receptor-associated factor 2 (TRAF2) determines NF-κB signaling in T cells.

Authors:  Takanori So; Pejman Soroosh; So-Young Eun; Amnon Altman; Michael Croft
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 7.  Apoptosis and the homeostatic control of immune responses.

Authors:  David Hildeman; Trine Jorgensen; John Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2007-07-20       Impact factor: 7.486

8.  OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.

Authors:  Naomi Kitamura; Satoshi Murata; Tomoyuki Ueki; Eiji Mekata; R Todd Reilly; Elizabeth M Jaffee; Tohru Tani
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

9.  Unconventional ligand activation of herpesvirus entry mediator signals cell survival.

Authors:  Timothy C Cheung; Marcos W Steinberg; Lisa M Oborne; Matthew G Macauley; Satoshi Fukuyama; Hideki Sanjo; Claire D'Souza; Paula S Norris; Klaus Pfeffer; Kenneth M Murphy; Mitchell Kronenberg; Patricia G Spear; Carl F Ware
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

Review 10.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.